Moreover, humans with no cognitive impairment, but levels of amyloid plaques similar to those of AD patients at autopsy (termed asymptomatic AD), had significantly less phospho-tau accumulation around plaques, implicating DN-associated phospho-tau in cognitive decline [63]. Here, MAPT is linked to Cognitive impairment.